Instrument Inactif

Autres langues Amniotics AB

Actions

AMNI

SE0015961016

Recherche biotechnologique et médicale

Autres langues

23/09	Global markets live: Meta, Google, Anthropic, Chevron, Glencore…
22/11/24	Magle Group resolves on a rights issue of approximately SEK 36.8 million
07/10/24	Swedish Companies Registration Office Registers Magle Group-Amniotics Merger
07/10/24	The merger between Magle Group and Amniotics has been completed
07/10/24	Magle Chemoswed Holding AB (OM:MAGLE) completed the acquisition of Amniotics AB (OM:AMNI).
04/10/24	Magle Group resolves on a new issue of consideration shares
27/09/24	Magle Chemoswed Holding AB (OM:MAGLE) completed the acquisition of Amniotics AB (OM:AMNI).
23/09/24	Swedish Companies Registration Office Clears Magle Group, Amniotics Merger
23/09/24	The Swedish Companies Registration Office has authorised the implementation of the merger plan between Magle Group and Amniotics
20/08/24	Amniotics H1 2024 - Merger with Magle
20/08/24	Amniotics AB Reports Earnings Results for the Half Year Ended June 30, 2024
06/08/24	Amniotics Gets Conditional Delisting Approval from Nasdaq Europe Amid Magle Chemoswed Deal
06/08/24	Amniotics Files for Delisting from Nasdaq First North Growth Market
06/08/24	Amniotics receives conditional approval to delist from Nasdaq First North Growth Market
06/08/24	Amniotics applies for delisting from Nasdaq First North Growth Market conditional upon completion of the merger with Magle Group
01/07/24	Magle Group publishes merger document regarding the merger with Amniotics
30/05/24	Statement from the Board of Directors of Amniotics regarding the merger with Magle Group
30/05/24	Magle Group and Amniotics merge to create a leader in high-quality life-changing healthcare innovations with a broadened CDMO offering
28/05/24	Amniotics AB Auditor Raises 'Going Concern' Doubt
21/05/24	Amniotics secures continued short-term capital needs by extending loan agreement and continued services under service agreement
20/05/24	Magle Group will not complete the public offer to the shareholders of Amniotics
20/05/24	Magle Chemoswed Holding AB (OM:MAGLE) cancelled the acquisition of 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other.
07/05/24	MAGLE GROUP REPORTS OUTCOME AND EXTENDS THE ACCEPTANCE PERIOD FOR THE PUBLIC TENDER OFFER TO THE SHAREHOLDERS OF AMNIOTICS
19/04/24	Magle Chemoswed Q1 - Expansion by acquisition
05/04/24	Magle Chemoswed Holding AB publishes offer document and announces updated timetable regarding the cash offer to the shareholders of Amniotics AB